InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Brown James F, 董事. Officer active across 1 company, notably Bellicum Pharmaceuticals, INC. In total, 1 filings have been recorded. History available since 4 January 2022. The latest transaction was filed on 4 January 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
James F. Brown is a Board Member at Bellicum Pharmaceuticals, Inc. He plays a key role in overseeing the company's activities and developing its strategy. Bellicum Pharmaceuticals, Inc. is a biopharmaceutical company focused on innovation in cancer treatment.